Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genetics and Genomics, |
RCV001269946 | SCV001450321 | pathogenic | not provided | 2017-10-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001269946 | SCV001574302 | pathogenic | not provided | 2023-11-25 | criteria provided, single submitter | clinical testing | This sequence change affects codon 954 of the COL2A1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the COL2A1 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with clinical features of Stickler syndrome (PMID: 20179744, 20513134). ClinVar contains an entry for this variant (Variation ID: 988535). Studies have shown that this variant alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 20179744, 20513134). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001269946 | SCV001811906 | pathogenic | not provided | 2024-03-03 | criteria provided, single submitter | clinical testing | Non-canonical splice site variant demonstrated to result in loss-of-function (PMID: 20513134); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31781920, 20179744, 34680973, 34169787, 27193475, 26443184, 20513134, 33726816) |
Institute of Human Genetics, |
RCV002294450 | SCV002587077 | likely pathogenic | Stickler syndrome type 1 | 2022-09-30 | criteria provided, single submitter | clinical testing | _x000D_ Criteria applied: PS3, PS4_MOD, PM2_SUP, PP3, PP4 |
Ce |
RCV001269946 | SCV004033201 | pathogenic | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | COL2A1: PVS1, PS4:Moderate, PM2:Supporting, PP1, PS3:Supporting |
Institute of Human Genetics Munich, |
RCV002294450 | SCV004045906 | pathogenic | Stickler syndrome type 1 | 2022-12-09 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001269946 | SCV005414075 | pathogenic | not provided | 2024-02-15 | criteria provided, single submitter | clinical testing | PP4, PM2, PS3, PS4 |
Genome Diagnostics Laboratory, |
RCV001269946 | SCV001808400 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001269946 | SCV001956980 | pathogenic | not provided | no assertion criteria provided | clinical testing |